Medications for Heart Failure
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Heart Failure.
Found 48 Approved Drugs for Heart Failure
Valsartan
Brand Names
Entresto, Amlodipine, Diovan, Sacubitril, Exforge
Valsartan
Brand Names
Entresto, Amlodipine, Diovan, Sacubitril, Exforge
Form: Pellet, Tablet, Solution
Method of administration: Oral
FDA approval date: March 06, 1998
Classification: Dihydropyridine Calcium Channel Blocker
Sacubitril and valsartan tablets are a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker, and are indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.
MetFORMIN
Brand Names
Glyburide-MetFORMIN, Janumet, Saxagliptin, Zituvimet, Invokamet, Pioglitazole, Sitagliptin, Segluromet, Actoplus, Riomet, Glumetza, Jentadueto, Xigduo, Trijardy, Pioglitazone, MetFORMIN Hydrochoride, Alogliptin, Kombiglyze, Dapagliflozin, Glipizide, Glyburide, Synjardy, Kazano
MetFORMIN
Brand Names
Glyburide-MetFORMIN, Janumet, Saxagliptin, Zituvimet, Invokamet, Pioglitazole, Sitagliptin, Segluromet, Actoplus, Riomet, Glumetza, Jentadueto, Xigduo, Trijardy, Pioglitazone, MetFORMIN Hydrochoride, Alogliptin, Kombiglyze, Dapagliflozin, Glipizide, Glyburide, Synjardy, Kazano
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: January 24, 2002
Classification: Dipeptidyl Peptidase 4 Inhibitor
Metformin hydrochloride extended-release tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 )
Aldactone
Generic Name
CaroSpir
Aldactone
Generic Name
CaroSpir
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: January 21, 1960
Classification: Aldosterone Antagonist
Spironolactone oral suspension is an antagonist of aldosterone indicated for: the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure.
DOBUTamine
Generic Name
DOBUTamine
DOBUTamine
Generic Name
DOBUTamine
Form: Injection
Method of administration: Intravenous
FDA approval date: September 23, 1993
Classification: beta-Adrenergic Agonist
Dobutamine is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Experience with intravenous dobutamine in controlled trials does not extend beyond 48 hours of repeated boluses and/or continuous infusions. Whether given orally, continuously intravenously, or intermittently intravenously, neither dobutamine nor any other cyclic-AMP-dependent inotrope has been shown in controlled trials to be safe or effective in the long-term treatment of congestive heart failure. In controlled trials of chronic oral therapy with various such agents, symptoms were not consistently alleviated, and the cyclic-AMP-dependent inotropes were consistently associated with increased risk of hospitalization and death. Patients with NYHA Class IV symptoms appeared to be at particular risk.
Coreg
Generic Name
Carvedilol
Coreg
Generic Name
Carvedilol
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: September 05, 2007
Classification: alpha-Adrenergic Blocker
Carvedilol tablets are an alpha/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure.
Showing 1-5 of 48
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances